HomeRAPP • NASDAQ
add
Rapport Therapeutics Inc
Previous close
$28.70
Day range
$28.80 - $30.12
Year range
$6.43 - $42.27
Market cap
1.41B USD
Avg Volume
387.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.99M | 38.57% |
Net income | -26.92M | -53.53% |
Net profit margin | — | — |
Earnings per share | -0.71 | -42.00% |
EBITDA | -29.73M | -38.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 513.03M | 59.99% |
Total assets | 535.32M | 61.66% |
Total liabilities | 23.71M | 195.22% |
Total equity | 511.62M | — |
Shares outstanding | 47.66M | — |
Price to book | 2.67 | — |
Return on assets | -18.27% | — |
Return on capital | -18.77% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -26.92M | -53.53% |
Cash from operations | -17.46M | -6.40% |
Cash from investing | -56.78M | -7.04% |
Cash from financing | 270.53M | 19,506.96% |
Net change in cash | 196.29M | 377.05% |
Free cash flow | -10.01M | 16.79% |
About
Founded
2022
Headquarters
Website
Employees
69
